These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1883913)
21. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells. Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946 [TBL] [Abstract][Full Text] [Related]
22. Suicide effect on rat gliomas mediated by recombinant adenovirus thymidine kinase/acyclovir system. Wang Q; Lu D; Xing Y; Xue J; Qiu X Chin Med J (Engl); 1998 Jun; 111(6):483-7. PubMed ID: 11245062 [TBL] [Abstract][Full Text] [Related]
23. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer. Cappuccini F; Yamamoto RS; DiSaia PJ; Grosen EA; Gatanaga M; Lucci JA; Ininns EK; Gatanaga T; Granger GA Lymphokine Cytokine Res; 1991 Jun; 10(3):225-9. PubMed ID: 1653048 [TBL] [Abstract][Full Text] [Related]
24. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Pollack IF; Erff M; Ashkenazi A Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907 [TBL] [Abstract][Full Text] [Related]
25. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123 [TBL] [Abstract][Full Text] [Related]
26. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model. Kido G; Wright JL; Merchant RE J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671 [TBL] [Abstract][Full Text] [Related]
27. Cryosurgery and rhTNF-α play synergistic effects on a rat cortex C6 glioma model. Huang KM; Peng M; Feng YQ; Huang H; Tu HJ; Luo J; Zhang L; Yuan XH; Wang LC Cryobiology; 2012 Feb; 64(1):43-9. PubMed ID: 21982953 [TBL] [Abstract][Full Text] [Related]
28. [MCNU delivery into malignant brain tumor and normal brain tissue by intravenous or intraarterial infusion]. Miyagami M; Tazoe M; Tsubokawa T Gan To Kagaku Ryoho; 1990 Feb; 17(2):275-80. PubMed ID: 2154161 [TBL] [Abstract][Full Text] [Related]
29. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Maron A; Gustin T; Le Roux A; Mottet I; Dedieu JF; Brion JP; Demeure R; Perricaudet M; Octave JN Gene Ther; 1996 Apr; 3(4):315-22. PubMed ID: 8732163 [TBL] [Abstract][Full Text] [Related]
32. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548 [TBL] [Abstract][Full Text] [Related]
33. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells. Iwamoto S; Shibuya I; Takeda K; Takeda M Biochem Biophys Res Commun; 1994 Feb; 199(1):70-7. PubMed ID: 8123048 [TBL] [Abstract][Full Text] [Related]
34. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517 [TBL] [Abstract][Full Text] [Related]
35. Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain. Kiwit JC; Schmitz KH; Daum L; Reifenberger G; Roosen N J Neurosurg; 1991 Oct; 75(4):597-603. PubMed ID: 1653310 [TBL] [Abstract][Full Text] [Related]
36. A simple nonisotopic in vitro bioassay for LT and TNF employing sodium fluoride-treated L-929 target cells that detects picogram quantities of LT and TNF and is as sensitive as TNF assays done with ELISA methodology. Jeffes EW; Schmitz K; Yamamoto R; Tomich JM; Beckman M; Nep R; Knauer M Lymphokine Cytokine Res; 1991 Apr; 10(1-2):147-51. PubMed ID: 1873356 [TBL] [Abstract][Full Text] [Related]
37. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma. Badgwell BD; Valentino DJ; Jeffes EB; Dieffenbach K; Dulkanchainun SB; Yamamoto RS; Granger GA; Jakowatz JG; Carson WE Cancer Immunol Immunother; 2003 Jan; 52(1):10-6. PubMed ID: 12536235 [TBL] [Abstract][Full Text] [Related]
38. Prevention of type I diabetes with lymphotoxin in BB rats. Takahashi K; Satoh J; Seino H; Zhu XP; Sagara M; Masuda T; Toyota T Clin Immunol Immunopathol; 1993 Dec; 69(3):318-23. PubMed ID: 8242903 [TBL] [Abstract][Full Text] [Related]
39. Enhanced cytokines delivery and intercellular adhesion molecule 1 (ICAM-1) expression in glioma by intracarotid infusion of bradykinin analog, RMP-7. Nakano S; Matsukado K; Black KL Neurol Res; 1997 Oct; 19(5):501-8. PubMed ID: 9329027 [TBL] [Abstract][Full Text] [Related]
40. Influence of recombinant interleukin-2 and tumor necrosis factor-alpha on the development of ethyl nitrosourea-induced brain tumors. Vaquero J; Arias A; Zurita M; Coca S; Oya S; Morales C Oncol Res; 1992; 4(7):275-80. PubMed ID: 1450489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]